Altimmune, Inc. Banner Image

Altimmune, Inc. has reached its limit for free report views

Work for Altimmune, Inc.? Upgrade Your Profile and unlock all your annual reports.

Altimmune, Inc.

  • Ticker ALT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Altimmune, Inc. Logo Image
  • 51-200 Employees
  • Based in Gaithersburg, Maryland
Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Their diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptideMore therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).
4.7 / 5.0 (172)

Altimmune, Inc. reports have an aggregate usefulness score of 4.7 based on 172 reviews.

Altimmune, Inc.

Most Recent Annual Report

Altimmune, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Report Locked. Altimmune, Inc. has reached its limit for free report views.

Older/Archived Annual Reports

Altimmune, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!